{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:37:50Z","timestamp":1771655870778,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.4158\/ep.14.9.1108","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T22:30:01Z","timestamp":1365201001000},"page":"1108-1114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Expression Analysis of Fibroblast Growth Factor-23, Matrix Extracellular Phosphoglycoprotein, Secreted Frizzled-Related Protein-4, and Fibroblast Growth Factor-7: Identification of Fibroblast Growth Factor-23 and Matrix Extracellular Phosphoglycoprotein as Major Factors Involved in Tumor-Induced Osteomalacia"],"prefix":"10.1016","volume":"14","author":[{"given":"Mouhammed Amir","family":"Habra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilo","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Chen Eileen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilbert J.","family":"Cote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"William A.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert F.","family":"Gagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana O.","family":"Hoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.14.9.1108_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.4158\/EP.14.9.1108_bb0010","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1210\/jc.2004-0406","article-title":"Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia","volume":"89","author":"Takeuchi","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.14.9.1108_bb0015","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(02)07846-7","article-title":"Localisation of mesenchymal tumours by somatostatin receptor imaging","volume":"359","author":"Jan de Beur","year":"2002","journal-title":"Lancet"},{"key":"10.4158\/EP.14.9.1108_bb0020","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJM199406093302304","article-title":"Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia","volume":"330","author":"Cai","year":"1994","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.14.9.1108_bb0025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S8756-3282(00)00334-3","article-title":"Tumor-induced osteomalacia and the regulation of phosphate homeostasis","volume":"27","author":"Kumar","year":"2000","journal-title":"Bone"},{"key":"10.4158\/EP.14.9.1108_bb0030","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1210\/er.2005-0019","article-title":"The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23","volume":"27","author":"White","year":"2006","journal-title":"Endocr Rev"},{"key":"10.4158\/EP.14.9.1108_bb0035","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.bone.2004.06.014","article-title":"Bone as a source of FGF23: regulation by phosphate?","volume":"35","author":"Mirams","year":"2004","journal-title":"Bone"},{"key":"10.4158\/EP.14.9.1108_bb0040","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/geno.2001.6553","article-title":"MEPE, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone","volume":"74","author":"Argiro","year":"2001","journal-title":"Genomics"},{"key":"10.4158\/EP.14.9.1108_bb0045","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1210\/jc.2004-0357","article-title":"Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors","volume":"90","author":"Carpenter","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.14.9.1108_bb0050","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jsbmb.2006.11.010","article-title":"The phosphatonins and the regulation of phosphate transport and vitamin D metabolism","volume":"103","author":"Sommer","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.4158\/EP.14.9.1108_bb0055","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","article-title":"Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain","volume":"277","author":"Yamashita","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.4158\/EP.14.9.1108_bb0060","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1210\/jcem.86.2.7408","article-title":"The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting","volume":"86","author":"White","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.14.9.1108_bb0065","doi-asserted-by":"crossref","first-page":"F1577","DOI":"10.1152\/ajprenal.00463.2006","article-title":"Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro","volume":"293","author":"Perwad","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.4158\/EP.14.9.1108_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-07-0095","article-title":"The emerging role of the fibroblast growth factor-23-Klotho axis in renal regulation of phosphate homeostasis","volume":"194","author":"Razzaque","year":"2007","journal-title":"J Endocrinol"},{"key":"10.4158\/EP.14.9.1108_bb0075","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"10.4158\/EP.14.9.1108_bb0080","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"key":"10.4158\/EP.14.9.1108_bb0085","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1210\/jc.2005-2105","article-title":"Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia","volume":"91","author":"Imel","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.14.9.1108_bb0090","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J Clin Invest"},{"key":"10.4158\/EP.14.9.1108_bb0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ajmg.a.30599","article-title":"Elevated fibroblast growth factor-23 in hypophosphatemic linear nevus sebaceous syndrome","volume":"134","author":"Hoffman","year":"2005","journal-title":"Am J Med Genet A"},{"key":"10.4158\/EP.14.9.1108_bb0100","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1523-1755.2005.00506.x","article-title":"Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules","volume":"68","author":"Baum","year":"2005","journal-title":"Kidney Int"},{"key":"10.4158\/EP.14.9.1108_bb0105","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumorinduced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4158\/EP.14.9.1108_bb0110","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP.14.9.1108_bb0115","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"key":"10.4158\/EP.14.9.1108_bb0120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/geno.2000.6235","article-title":"MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia","volume":"67","author":"Rowe","year":"2000","journal-title":"Genomics"},{"key":"10.4158\/EP.14.9.1108_bb0125","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00774-003-0468-9","article-title":"Matrix extracellular phosphoglycoprotein (MEPE) is highly expressed in osteocytes in human bone","volume":"22","author":"Nampei","year":"2004","journal-title":"J Bone Miner Metab"},{"key":"10.4158\/EP.14.9.1108_bb0130","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1074\/jbc.M203250200","article-title":"Targeted disruption of the osteoblast\/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass","volume":"278","author":"Gowen","year":"2003","journal-title":"J Biol Chem"},{"key":"10.4158\/EP.14.9.1108_bb0135","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1681\/ASN.2004121060","article-title":"Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia","volume":"16","author":"Liu","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.4158\/EP.14.9.1108_bb0140","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/ndt\/gfm535","article-title":"Matrix extracellular phosphoglycoprotein causes phosphaturia in rats by inhibiting tubular phosphate reabsorption","volume":"23","author":"Dobbie","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.4158\/EP.14.9.1108_bb0145","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1006\/cbir.1995.1085","article-title":"Keratinocyte growth factor","volume":"19","author":"Rubin","year":"1995","journal-title":"Cell Biol Int"},{"key":"10.4158\/EP.14.9.1108_bb0150","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ymthe.2004.04.013","article-title":"FGF-7 expression enhances the performance of bioengineered skin","volume":"10","author":"Erdag","year":"2004","journal-title":"Mol Ther"},{"key":"10.4158\/EP.14.9.1108_bb0155","article-title":"The Wnts","volume":"3","author":"Miller","year":"2002","journal-title":"Genome Biol"},{"key":"10.4158\/EP.14.9.1108_bb0160","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00424-005-1495-2","article-title":"Secreted frizzledrelated protein-4 reduces sodium-phosphate co-transporter abundance and activity in proximal tubule cells","volume":"451","author":"Berndt","year":"2006","journal-title":"Pflugers Arch"},{"key":"10.4158\/EP.14.9.1108_bb0165","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI18563","article-title":"Secreted frizzledrelated protein 4 is a potent tumor-derived phosphaturic agent","volume":"112","author":"Berndt","year":"2003","journal-title":"J Clin Invest"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20416404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20416404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/24M4247000415823.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:48:39Z","timestamp":1761515319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20416404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1530891X20416404"],"URL":"https:\/\/doi.org\/10.4158\/ep.14.9.1108","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression Analysis of Fibroblast Growth Factor-23, Matrix Extracellular Phosphoglycoprotein, Secreted Frizzled-Related Protein-4, and Fibroblast Growth Factor-7: Identification of Fibroblast Growth Factor-23 and Matrix Extracellular Phosphoglycoprotein as Major Factors Involved in Tumor-Induced Osteomalacia","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.14.9.1108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}